About

Integrated Pharmatek

Integrated Pharmatek Private Limited is a Private incorporated on 18 June 1997. It is classified as Non-govt company and is registered at Registrar of Companies, Patna. Its authorized share capital is Rs. 1,000,000 and its paid up capital is Rs. 144,000.

Integrated Pharmatek Private Limited’s Annual General Meeting (AGM) was last held on 30 September 2016 and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 31 March 2016.

https://www.youtube.com/watch?v=L_PX_UuMAdU

Our Products

Career

Integrated Pharmatek employees handpicked professionals not just for their knowledge and experience but for their zeal to make a difference to the world of healthcare.
The company believes that our biggest assets are the employees, who lead us to prosperity and growth in the future. Driven by the vision, “None shall be denied”, Integrated focus has always been on making affordable, world-class medicines with a reputation for uncompromising quality standards across the world.

Testimonials

We are fully satisfied with the services provided by Integrated Pharmatek. The engineers have expertise in their domain. I am rating 5 out of 5 overall.

Packaging Manager, Sun Pharma
Integrated Pharmatek has helped us standardize many of our IV admixtures. Standardization has improved both quality and helped us to eliminate waste. Additionally, the service levels that Integrated Pharmatek provides are among the best of any of our vendors.

Packaging Manager, UTL Pharma

About Us

Integrated Pharmatek Private Limited is a Private incorporated on 18 June 1997. It is classified as Non-govt company and is registered at Registrar of Companies, Patna.

Useful Links

Head Office

318, 3rd Floor, DLF Qutub Plaza,
DLF City Phase-1, Gurgaon,
Haryana,122002
integratedpharm@gmail.com
0124-4188193

At Integrated Pharmatek we manufacture niche and complex Pharma products under the pressure of expectation

We deliver finished formulation and APIs from award winning facilities while improving our R&D and discovery pipeline